Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
154634333 184632 0 None - 1 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 184632 0 None - 1 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
326869 112313 3 None - 1 Human 9.0 pEC50 = 9.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112313 3 None - 1 Human 9.0 pEC50 = 9.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
164610101 184292 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184292 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
12138435 67715 25 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 67715 25 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
70696510 74953 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
CHEMBL2037458 74953 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
70682869 77028 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
CHEMBL2086422 77028 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
5281605 204018 108 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 204018 108 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
145950576 162329 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
CHEMBL4173352 162329 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
70687103 77349 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
CHEMBL2089222 77349 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
70687102 77348 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
CHEMBL2089221 77348 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
5281855 201155 101 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 201155 101 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
53257379 67719 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
CHEMBL1914580 67719 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
135403802 26326 52 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 26326 52 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
411 2555 86 None -144 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 2555 86 None -144 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 2555 86 None -144 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
4488 201332 105 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 201332 105 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
70692387 74960 2 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 259 1 2 2 3.0 Cc1c(C(=O)O)[nH]c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037465 74960 2 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 259 1 2 2 3.0 Cc1c(C(=O)O)[nH]c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
66561718 74957 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037462 74957 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
154634327 184156 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184156 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
153273978 194252 1 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 194252 1 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 194252 1 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
70681838 74949 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
CHEMBL2037453 74949 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
70689185 77352 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(C(F)(F)F)cc1 10.1021/ml300076u
CHEMBL2089225 77352 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(C(F)(F)F)cc1 10.1021/ml300076u
72103 43162 23 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL150764 43162 23 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634331 183965 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 183965 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145951566 162215 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 162215 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
145951566 162215 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 162215 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
145959592 161800 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4164993 161800 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
411 2555 86 None -144 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 2555 86 None -144 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 2555 86 None -144 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
135399235 4071 55 None -26 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
2919 4071 55 None -26 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
5722 4071 55 None -26 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
CHEMBL28079 4071 55 None -26 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
12533774 184936 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 184936 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
53258793 67728 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914589 67728 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
5281672 56260 116 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 56260 116 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
70694439 74955 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037460 74955 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
154634337 184751 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 184751 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
16103462 67727 16 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 67727 16 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
2918 2174 117 None -4570 4 Human 3.8 pEC50 = 3.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2012.04.057
3845 2174 117 None -4570 4 Human 3.8 pEC50 = 3.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2012.04.057
CHEMBL299155 2174 117 None -4570 4 Human 3.8 pEC50 = 3.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2012.04.057
DB11937 2174 117 None -4570 4 Human 3.8 pEC50 = 3.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2012.04.057
12138434 67720 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
CHEMBL1914581 67720 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
66561717 74951 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037456 74951 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
135399235 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
135399235 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
2919 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
5722 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
CHEMBL28079 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
70691268 77356 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
CHEMBL2089229 77356 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
135399235 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 4071 55 None -26 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
151577785 185971 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 185971 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
45093111 77353 8 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 208 1 3 4 1.9 Cc1c(C(=O)O)oc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089226 77353 8 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 208 1 3 4 1.9 Cc1c(C(=O)O)oc2cc(O)c(O)cc12 10.1021/ml300076u
154634333 184632 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 184632 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
154634330 185370 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 185370 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634321 185415 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185415 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
9990345 67723 30 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
CHEMBL1914584 67723 30 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
70697499 77339 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 297 3 3 4 3.1 Cc1ccc(Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
CHEMBL2089195 77339 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 297 3 3 4 3.1 Cc1ccc(Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
110720191 161907 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4166802 161907 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
70692386 74958 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037463 74958 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
16103462 67727 16 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 67727 16 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
73157 193689 26 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 193689 26 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
154634326 184509 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 184509 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
149708825 185809 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 185809 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
53258795 67729 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 67729 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
145959306 161765 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4164556 161765 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
145949189 162187 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 162187 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
2920 2948 98 None 2344 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
54742459 2948 98 None 2344 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
8546 2948 98 None 2344 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
CHEMBL177880 2948 98 None 2344 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
154634332 184544 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 184544 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145949189 162187 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 162187 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
135399235 4071 55 None -26 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
2919 4071 55 None -26 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
5722 4071 55 None -26 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
CHEMBL28079 4071 55 None -26 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
70693381 77344 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 269 2 4 3 2.9 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccccc1 10.1021/ml300076u
CHEMBL2089217 77344 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 269 2 4 3 2.9 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccccc1 10.1021/ml300076u
145958445 161582 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161574 161582 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
152243845 184316 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 184316 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
145955278 162009 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4168406 162009 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
152550147 184746 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 184746 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634334 184843 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 184843 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70681838 74949 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
CHEMBL2037453 74949 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
70687102 77348 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
CHEMBL2089221 77348 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
53258795 67729 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 67729 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
5281605 204018 108 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 204018 108 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
53258796 67730 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914591 67730 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
3715518 29545 7 None -13 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 379 9 1 3 5.2 COc1ccc(CNCCC(c2ccc(F)cc2)c2ccc(OC)cc2)cc1 nan
CHEMBL1386881 29545 7 None -13 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 379 9 1 3 5.2 COc1ccc(CNCCC(c2ccc(F)cc2)c2ccc(OC)cc2)cc1 nan
119405 96696 66 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
CHEMBL267855 96696 66 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
150386356 184563 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 184563 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
119405 96696 66 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
CHEMBL267855 96696 66 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
73157 193689 26 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 193689 26 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
152684818 184409 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 184409 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
66561718 74957 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037462 74957 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
70687103 77349 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
CHEMBL2089222 77349 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
66561717 74951 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037456 74951 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
70695483 77345 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
CHEMBL2089218 77345 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
70689184 77347 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
CHEMBL2089220 77347 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
154634327 184156 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184156 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
154634326 184509 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 184509 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70691267 77351 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(Cl)cc1 10.1021/ml300076u
CHEMBL2089224 77351 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(Cl)cc1 10.1021/ml300076u
944642 58808 11 None -30 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 324 5 2 4 4.2 CCOc1ccc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)c1 nan
CHEMBL1698243 58808 11 None -30 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 324 5 2 4 4.2 CCOc1ccc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)c1 nan
70692386 74958 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037463 74958 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
70690212 74954 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 302 2 1 3 4.3 O=C(O)c1sc2c(Br)csc2c1C1CC1 10.1016/j.bmcl.2012.04.057
CHEMBL2037459 74954 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 302 2 1 3 4.3 O=C(O)c1sc2c(Br)csc2c1C1CC1 10.1016/j.bmcl.2012.04.057
66561793 74961 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037466 74961 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
150149078 185762 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 185762 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
3884 44247 72 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 44247 72 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
152727536 183905 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 183905 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634322 184798 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 184798 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
5281855 201155 101 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 201155 101 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
57134579 162082 14 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4169520 162082 14 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145957901 161526 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 161526 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145957901 161526 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 161526 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
5281672 56260 116 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 56260 116 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
145951357 162214 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 162214 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
154634320 186028 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 186028 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
70683937 74691 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
CHEMBL2035007 74691 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
145951357 162214 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 162214 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
12138435 67715 25 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 67715 25 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
5215 2354 128 None -1 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 2354 128 None -1 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 2354 128 None -1 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
154634315 184295 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852718 184295 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
56646802 67716 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
CHEMBL1914577 67716 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
135399235 4071 55 None -26 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 4071 55 None -26 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 4071 55 None -26 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 4071 55 None -26 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
16103482 67724 1 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
CHEMBL1914585 67724 1 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
70695483 77345 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
CHEMBL2089218 77345 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
145971743 162554 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 162554 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
145971743 162554 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 162554 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
11674067 67717 21 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
CHEMBL1914578 67717 21 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
145953959 162127 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4170205 162127 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
70686064 74950 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037454 74950 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
154634324 185129 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 185129 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70686065 74959 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037464 74959 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
145971240 162537 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 162537 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145971240 162537 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 162537 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
5491415 74942 15 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 74942 15 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
154634318 185417 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 185417 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
70696510 74953 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
CHEMBL2037458 74953 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
2918 2174 117 None -4570 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
3845 2174 117 None -4570 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
CHEMBL299155 2174 117 None -4570 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
DB11937 2174 117 None -4570 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
70691265 77341 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 325 4 3 5 2.9 Cc1ccc(C(=O)Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
CHEMBL2089197 77341 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 325 4 3 5 2.9 Cc1ccc(C(=O)Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
4488 201332 105 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 201332 105 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
145956623 161464 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 161464 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
145956623 161464 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 161464 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
70682865 77342 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 1 4 3 2.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1Br 10.1021/ml300076u
CHEMBL2089199 77342 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 1 4 3 2.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1Br 10.1021/ml300076u
135399235 4071 55 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4071 55 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4071 55 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4071 55 None -26 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
660319 10900 88 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
CHEMBL1173787 10900 88 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
68324914 185149 31 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 185149 31 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
13950957 156786 6 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 156786 6 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
15774808 77338 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 283 3 3 4 2.8 O=C(O)c1cc2cc(O)c(O)cc2n1Cc1ccccc1 10.1021/ml300076u
CHEMBL2089194 77338 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 283 3 3 4 2.8 O=C(O)c1cc2cc(O)c(O)cc2n1Cc1ccccc1 10.1021/ml300076u
145958495 161649 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 161649 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
70687104 77350 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 305 2 4 3 3.2 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(F)cc(F)c1 10.1021/ml300076u
CHEMBL2089223 77350 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 305 2 4 3 3.2 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(F)cc(F)c1 10.1021/ml300076u
70689180 77340 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 311 4 3 5 2.6 O=C(Cn1c(C(=O)O)cc2cc(O)c(O)cc21)c1ccccc1 10.1021/ml300076u
CHEMBL2089196 77340 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 311 4 3 5 2.6 O=C(Cn1c(C(=O)O)cc2cc(O)c(O)cc21)c1ccccc1 10.1021/ml300076u
145958495 161649 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 161649 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
10868388 161584 43 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161599 161584 43 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145954149 162049 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 162049 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
154634323 184021 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 184021 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145954149 162049 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 162049 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
15774807 77336 26 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089192 77336 26 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
53258898 67731 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914592 67731 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
70697498 77337 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089193 77337 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
21337669 67721 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
CHEMBL1914582 67721 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
145952561 162409 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4174783 162409 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
70691268 77356 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
CHEMBL2089229 77356 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
135403802 26326 52 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 26326 52 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
3884 44247 72 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 44247 72 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
154634328 184518 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 184518 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164627011 185824 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 185824 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
2920 2948 98 None 2344 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
54742459 2948 98 None 2344 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
8546 2948 98 None 2344 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
CHEMBL177880 2948 98 None 2344 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
6619478 25732 3 None -9 2 Human 6.3 pEC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
CHEMBL1354041 25732 3 None -9 2 Human 6.3 pEC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
70683937 74691 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
CHEMBL2035007 74691 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
145955027 161990 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 161990 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
145955027 161990 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 161990 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
5491415 74942 15 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 74942 15 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
44351698 120335 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
CHEMBL3558475 120335 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
145958540 161720 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 161720 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
6622007 38806 6 None -9 4 Human 5.3 pEC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
CHEMBL1468612 38806 6 None -9 4 Human 5.3 pEC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
145958540 161720 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 161720 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
70683939 74956 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037461 74956 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70686065 74959 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037464 74959 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
70690213 74963 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037468 74963 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
135399235 4071 55 None -26 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
2919 4071 55 None -26 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
5722 4071 55 None -26 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
CHEMBL28079 4071 55 None -26 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
21337671 67722 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
CHEMBL1914583 67722 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
153273978 194252 1 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 194252 1 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 194252 1 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
164627011 185824 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 185824 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
70694439 74955 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037460 74955 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
145971442 162477 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 162477 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145971442 162477 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 162477 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
5280343 187691 119 None -8 7 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 187691 119 None -8 7 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 187691 119 None -8 7 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
154634332 184544 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 184544 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
16103465 67726 2 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914587 67726 2 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
16103462 67727 16 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL1914588 67727 16 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
145952912 161894 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 161894 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
135399235 4071 55 None -26 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 4071 55 None -26 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 4071 55 None -26 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 4071 55 None -26 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
70682869 77028 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
CHEMBL2086422 77028 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
145954727 161871 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 161871 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145952912 161894 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 161894 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
70684936 77355 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089228 77355 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
135399235 4071 55 None -26 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 4071 55 None -26 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 4071 55 None -26 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 4071 55 None -26 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
154634321 185415 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185415 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145954727 161871 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 161871 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
135399235 4071 55 None -26 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
2919 4071 55 None -26 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
5722 4071 55 None -26 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
CHEMBL28079 4071 55 None -26 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
66561793 74961 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037466 74961 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
16103462 67727 16 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 67727 16 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
16103462 67727 16 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 67727 16 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
15774807 77336 26 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089192 77336 26 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
45489602 58963 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 58963 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
154634336 185486 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 185486 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
45489602 58963 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 58963 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
21337670 67718 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
CHEMBL1914579 67718 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
70686064 74950 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037454 74950 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
44351698 120335 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
CHEMBL3558475 120335 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
5328791 203276 60 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 203276 60 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
1024 16311 99 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 16311 99 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
5215 2354 128 None -1 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 2354 128 None -1 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 2354 128 None -1 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
20259231 77354 15 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 210 1 3 4 2.0 O=C(O)c1cc2cc(O)c(O)cc2s1 10.1021/ml300076u
CHEMBL2089227 77354 15 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 210 1 3 4 2.0 O=C(O)c1cc2cc(O)c(O)cc2s1 10.1021/ml300076u
70689184 77347 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
CHEMBL2089220 77347 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
70697498 77337 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089193 77337 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
326869 112313 3 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112313 3 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
164610101 184292 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184292 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
5280343 187691 119 None -8 7 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 187691 119 None -8 7 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 187691 119 None -8 7 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
154634314 186027 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 186027 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145953203 161988 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 161988 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
16103462 67727 16 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL1914588 67727 16 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
145953203 161988 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 161988 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
70681839 74962 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 221 2 2 2 3.1 Cc1c(C(=O)O)[nH]c2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037467 74962 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 221 2 2 2 3.1 Cc1c(C(=O)O)[nH]c2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70689183 77346 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 270 2 4 4 2.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccnc1 10.1021/ml300076u
CHEMBL2089219 77346 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 270 2 4 4 2.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccnc1 10.1021/ml300076u
145952039 162258 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 162258 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145952039 162258 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 162258 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145974046 162462 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 162462 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
151271218 185573 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 185573 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
145959908 161513 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 161513 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
145952453 162238 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 162238 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
145959908 161513 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 161513 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
145952453 162238 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 162238 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
145974046 162462 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 162462 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
70690213 74963 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037468 74963 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
70684936 77355 0 None - 1 Human 4.0 pEC50 = 4.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089228 77355 0 None - 1 Human 4.0 pEC50 = 4.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
154634335 183901 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 183901 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
154634316 185760 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 185760 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
53258899 67725 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914586 67725 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
57697 14328 33 None - 1 Rat 7.0 pEC50 = 7.0 Functional
Agonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assayAgonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assay
ChEMBL 228 1 1 6 0.2 Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12 10.1021/acsmedchemlett.7b00510
CHEMBL1201198 14328 33 None - 1 Rat 7.0 pEC50 = 7.0 Functional
Agonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assayAgonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assay
ChEMBL 228 1 1 6 0.2 Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12 10.1021/acsmedchemlett.7b00510
70683939 74956 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037461 74956 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70683938 74952 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 200 1 2 4 2.4 O=C(O)c1sc2ccsc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037457 74952 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 200 1 2 4 2.4 O=C(O)c1sc2ccsc2c1O 10.1016/j.bmcl.2012.04.057
5328791 203276 60 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 203276 60 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
154634333 184632 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 184632 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
326869 112313 3 None - 1 Human 9.1 pIC50 = 9.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112313 3 None - 1 Human 9.1 pIC50 = 9.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634333 184632 0 None - 1 Human 8.0 pIC50 = 8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 184632 0 None - 1 Human 8.0 pIC50 = 8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
3110120 41674 10 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 10 3 5 5.2 CCCCCOC(=O)c1ccc(NC(=O)c2cccc(NC(=O)c3ccccc3C(=O)O)c2)cc1 nan
CHEMBL1494365 41674 10 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 10 3 5 5.2 CCCCCOC(=O)c1ccc(NC(=O)c2cccc(NC(=O)c3ccccc3C(=O)O)c2)cc1 nan
644413 33312 5 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 315 1 1 5 2.0 CN1C=CC2=C(C#N)C(N)C(C#N)(C#N)C(c3ccccc3)C2C1 nan
CHEMBL1420573 33312 5 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 315 1 1 5 2.0 CN1C=CC2=C(C#N)C(N)C(C#N)(C#N)C(c3ccccc3)C2C1 nan
9581006 59076 2 None 12 3 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 379 5 2 6 3.0 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709028 59076 2 None 12 3 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 379 5 2 6 3.0 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccccc1 nan
18296 69519 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
5351211 69519 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
5474842 69519 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
6326610 69519 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
CHEMBL193872 69519 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
CHEMBL466853 69519 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
152550147 184746 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 184746 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634315 184295 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852718 184295 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
53257379 67719 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
CHEMBL1914580 67719 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
53258793 67728 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914589 67728 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
135399235 4071 55 None -26 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4071 55 None -26 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4071 55 None -26 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4071 55 None -26 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
151271218 185573 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 185573 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
4811966 43442 6 None 2 5 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 4 1 4 3.3 CC(NC(=O)Cn1ncc(Cl)c(Cl)c1=O)C12CC3CC(CC(C3)C1)C2 nan
CHEMBL1510156 43442 6 None 2 5 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 4 1 4 3.3 CC(NC(=O)Cn1ncc(Cl)c(Cl)c1=O)C12CC3CC(CC(C3)C1)C2 nan
16103462 67727 16 None - 1 Human 7.0 pIC50 = 7.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 67727 16 None - 1 Human 7.0 pIC50 = 7.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
145957901 161526 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 161526 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145951357 162214 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 162214 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
5602180 55218 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
CHEMBL1416442 55218 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
CHEMBL1620242 55218 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
16195500 41488 8 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
CHEMBL1492565 41488 8 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
9581008 59234 3 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 59234 3 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
150386356 184563 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 184563 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
2963825 47438 10 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 382 4 1 6 4.4 O=C(Nc1nc2ccccc2s1)c1ccc(N2CCCCC2)c([N+](=O)[O-])c1 nan
CHEMBL1547464 47438 10 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 382 4 1 6 4.4 O=C(Nc1nc2ccccc2s1)c1ccc(N2CCCCC2)c([N+](=O)[O-])c1 nan
2259994 41165 8 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 262 2 0 4 1.9 CN1C(=O)/C(=C\c2ccc(N(C)C)cc2)OC1=S nan
CHEMBL1490312 41165 8 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 262 2 0 4 1.9 CN1C(=O)/C(=C\c2ccc(N(C)C)cc2)OC1=S nan
135549592 107956 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 369 7 4 6 1.4 COc1ccc(/C=C\C(=O)NCC(=O)N/N=C/c2ccc(O)cc2O)cc1 nan
CHEMBL3198952 107956 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 369 7 4 6 1.4 COc1ccc(/C=C\C(=O)NCC(=O)N/N=C/c2ccc(O)cc2O)cc1 nan
1416931 23215 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1333032 23215 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
1348328 31570 7 None 16 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C/C=C/c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1406190 31570 7 None 16 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C/C=C/c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
5334489 45705 7 None 10 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 7 1 4 5.3 CCN(CC)c1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)c(OC(C)C)c1 nan
CHEMBL1532412 45705 7 None 10 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 7 1 4 5.3 CCN(CC)c1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)c(OC(C)C)c1 nan
4137407 29598 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 3 1 7 4.6 Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
CHEMBL1387336 29598 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 3 1 7 4.6 Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
152684818 184409 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 184409 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
5733585 40729 10 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
CHEMBL1487024 40729 10 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
655684 40848 8 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 1 1 5 3.3 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3cccc(Cl)c3Cl)C2C1 nan
CHEMBL1487918 40848 8 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 1 1 5 3.3 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3cccc(Cl)c3Cl)C2C1 nan
9990345 67723 30 None - 1 Human 4.9 pIC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
CHEMBL1914584 67723 30 None - 1 Human 4.9 pIC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
135399235 4071 55 None -26 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4071 55 None -26 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4071 55 None -26 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4071 55 None -26 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
6484583 37005 4 None -89 3 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]
ChEMBL 410 5 1 5 2.6 COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(Cl)cc1 nan
CHEMBL1453578 37005 4 None -89 3 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]
ChEMBL 410 5 1 5 2.6 COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(Cl)cc1 nan
9581013 59398 3 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
CHEMBL1723578 59398 3 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
1348329 26043 12 None 3 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1357976 26043 12 None 3 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
145952561 162409 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4174783 162409 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
13950957 156786 6 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 156786 6 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
2961024 44677 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 452 8 2 4 5.7 CCOc1ccc(NC(=O)C(C)Oc2ccccc2C(=O)Nc2ccc(C)c(Cl)c2)cc1 nan
CHEMBL1523126 44677 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 452 8 2 4 5.7 CCOc1ccc(NC(=O)C(C)Oc2ccccc2C(=O)Nc2ccc(C)c(Cl)c2)cc1 nan
149708825 185809 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 185809 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
24792210 54905 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1351967 54905 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1617564 54905 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
145953959 162127 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4170205 162127 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
72652 34624 56 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 309 0 0 3 3.5 O=c1cc(C(F)(F)F)c2cc3c4c(c2o1)CCCN4CCC3 nan
CHEMBL1431610 34624 56 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 309 0 0 3 3.5 O=c1cc(C(F)(F)F)c2cc3c4c(c2o1)CCCN4CCC3 nan
151577785 185971 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 185971 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
135475176 107538 9 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
135517099 107538 9 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
CHEMBL3194571 107538 9 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
2745687 920 28 None 10 3 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
9741 920 28 None 10 3 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
CHEMBL1708510 920 28 None 10 3 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
1346721 29605 10 None 1 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 440 7 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1 nan
CHEMBL1387413 29605 10 None 1 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 440 7 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1 nan
145956623 161464 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 161464 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
3153499 32360 18 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 344 3 0 5 2.5 CS(=O)(=O)N1N=C(c2ccccc2)CC1c1ccc2c(c1)OCO2 nan
CHEMBL1412529 32360 18 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 344 3 0 5 2.5 CS(=O)(=O)N1N=C(c2ccccc2)CC1c1ccc2c(c1)OCO2 nan
16196320 54774 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
3394229 54774 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
5813410 54774 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
CHEMBL1308547 54774 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
CHEMBL1616589 54774 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
1382708 29650 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1387749 29650 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
4362054 25886 7 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 495 9 2 8 4.3 CCOc1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1355774 25886 7 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 495 9 2 8 4.3 CCOc1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
152727536 183905 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 183905 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
24761764 52533 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 5 1 3 4.3 CC(NS(=O)(=O)OCC(Cl)(Cl)Cl)c1ccc(C(C)(C)C)cc1 nan
CHEMBL1595152 52533 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 5 1 3 4.3 CC(NS(=O)(=O)OCC(Cl)(Cl)Cl)c1ccc(C(C)(C)C)cc1 nan
16103482 67724 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
CHEMBL1914585 67724 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
6518655 108320 7 None 2 3 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 528 7 1 7 5.5 COc1ccc(/N=C2\S/C(=C\c3ccc(N4CCOCC4)o3)C(=O)N2CCc2c[nH]c3ccccc23)cc1 nan
CHEMBL3209511 108320 7 None 2 3 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 528 7 1 7 5.5 COc1ccc(/N=C2\S/C(=C\c3ccc(N4CCOCC4)o3)C(=O)N2CCc2c[nH]c3ccccc23)cc1 nan
154634327 184156 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184156 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
154634324 185129 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 185129 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164627011 185824 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 185824 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
154634326 184509 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 184509 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
150386356 184563 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 184563 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
1382708 29650 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1387749 29650 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
2885134 44188 8 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 373 6 2 5 5.0 CCOc1ccc2nc3cc(NCc4ccc(OC)cc4)ccc3c(N)c2c1 nan
CHEMBL1518827 44188 8 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 373 6 2 5 5.0 CCOc1ccc2nc3cc(NCc4ccc(OC)cc4)ccc3c(N)c2c1 nan
45917986 59043 7 None -6 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 314 2 0 4 4.4 Cc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1 nan
CHEMBL1707517 59043 7 None -6 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 314 2 0 4 4.4 Cc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1 nan
2286888 40839 10 None 11 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 466 8 2 5 5.0 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)cc2)C1=O)=C\c1ccccc1 nan
CHEMBL1487870 40839 10 None 11 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 466 8 2 5 5.0 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)cc2)C1=O)=C\c1ccccc1 nan
2247463 27386 9 None 15 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 515 8 3 7 4.6 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(C(C)C)cc3)cc2)s1 nan
CHEMBL1369492 27386 9 None 15 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 515 8 3 7 4.6 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(C(C)C)cc3)cc2)s1 nan
154634328 184518 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 184518 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
152727536 183905 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 183905 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
145954149 162049 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 162049 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
2745687 920 28 None 10 3 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
9741 920 28 None 10 3 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
CHEMBL1708510 920 28 None 10 3 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
8072340 55552 6 None -1 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
CHEMBL1517609 55552 6 None -1 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
CHEMBL1623159 55552 6 None -1 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
1205881 35936 5 None 23 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1444708 35936 5 None 23 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
21337669 67721 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
CHEMBL1914582 67721 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
1231538 27311 23 None -1 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1368962 27311 23 None -1 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
3596034 42084 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 308 2 0 4 3.0 CCN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
CHEMBL1498210 42084 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 308 2 0 4 3.0 CCN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
9581010 58868 3 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1700467 58868 3 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
154634337 184751 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 184751 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
145971743 162554 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 162554 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
9581010 58868 3 None - 1 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1700467 58868 3 None - 1 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
152684818 184409 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 184409 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
21157241 71537 4 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 381 5 1 5 2.3 COc1ccc(/C=c2\s/c(=C/C(=O)c3ccc(C)cc3)[nH]c2=O)c(OC)c1 nan
CHEMBL1970711 71537 4 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 381 5 1 5 2.3 COc1ccc(/C=c2\s/c(=C/C(=O)c3ccc(C)cc3)[nH]c2=O)c(OC)c1 nan
1502520 34278 21 None -9 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
CHEMBL1428840 34278 21 None -9 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
15945506 47757 5 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 5 1 4 5.8 CC(=O)c1ccc(NC(=O)C(C)n2nc(-c3ccccc3)c3cc(Cl)ccc32)cc1 nan
CHEMBL1550295 47757 5 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 5 1 4 5.8 CC(=O)c1ccc(NC(=O)C(C)n2nc(-c3ccccc3)c3cc(Cl)ccc32)cc1 nan
154634326 184509 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 184509 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634321 185415 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185415 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
152243845 184316 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 184316 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
2770749 55738 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
5708223 55738 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
5830170 55738 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
CHEMBL1572785 55738 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
CHEMBL1624721 55738 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
53258796 67730 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914591 67730 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
2277094 48751 10 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1560901 48751 10 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
11674067 67717 21 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
CHEMBL1914578 67717 21 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
2526579 54482 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 423 12 1 7 5.0 CCN(CC)CCCNc1ccc(-c2nnc(-c3ccc(OCC(C)C)cc3)o2)cn1 nan
CHEMBL1612267 54482 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 423 12 1 7 5.0 CCN(CC)CCCNc1ccc(-c2nnc(-c3ccc(OCC(C)C)cc3)o2)cn1 nan
6489901 55871 4 None 1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
CHEMBL1576905 55871 4 None 1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
CHEMBL1626041 55871 4 None 1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
326869 112313 3 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112313 3 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634321 185415 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185415 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634332 184544 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 184544 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
68324914 185149 31 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 185149 31 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
154634328 184518 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 184518 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145958495 161649 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 161649 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
150149078 185762 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 185762 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
5144920 21148 3 None 1 2 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 424 3 1 7 4.3 Cc1c(C(=O)Nc2ccc3c(c2)OCCO3)sc2ncnc(N3CCC(C)CC3)c12 nan
CHEMBL1314099 21148 3 None 1 2 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 424 3 1 7 4.3 Cc1c(C(=O)Nc2ccc3c(c2)OCCO3)sc2ncnc(N3CCC(C)CC3)c12 nan
4557537 37865 4 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 424 3 1 7 4.3 Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
CHEMBL1460894 37865 4 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 424 3 1 7 4.3 Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
6203183 52073 8 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 7 3 8 3.4 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
CHEMBL1589711 52073 8 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 7 3 8 3.4 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
6876400 72643 4 None 3 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 8 2 6 5.0 CCOc1ccc(/C=N/NC(=O)Cc2csc(Nc3cccc(C(F)(F)F)c3)n2)cc1 nan
CHEMBL2007593 72643 4 None 3 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 8 2 6 5.0 CCOc1ccc(/C=N/NC(=O)Cc2csc(Nc3cccc(C(F)(F)F)c3)n2)cc1 nan
154634324 185129 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 185129 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145958540 161720 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 161720 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
145952912 161894 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 161894 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
9581015 59087 3 None - 1 Human 6.7 pIC50 = 6.7 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709632 59087 3 None - 1 Human 6.7 pIC50 = 6.7 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
3243122 46142 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 421 3 0 5 4.6 COc1ccc2nc3oc(C(=O)N4CCN(c5cccc(Cl)c5)CC4)cc3cc2c1 nan
CHEMBL1536710 46142 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 421 3 0 5 4.6 COc1ccc2nc3oc(C(=O)N4CCN(c5cccc(Cl)c5)CC4)cc3cc2c1 nan
5731274 52071 9 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 468 8 1 6 4.8 CCOC(=O)c1ccc(NC(=O)CCCN2C(=O)/C(=C/c3ccc(C)cc3)SC2=S)cc1 nan
CHEMBL1589694 52071 9 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 468 8 1 6 4.8 CCOC(=O)c1ccc(NC(=O)CCCN2C(=O)/C(=C/c3ccc(C)cc3)SC2=S)cc1 nan
21337670 67718 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
CHEMBL1914579 67718 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
8108341 37396 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 364 7 1 3 5.1 O=C(O)COc1ccc(/C=C/C(=O)c2ccc(C3CCCCC3)cc2)cc1 nan
CHEMBL1457048 37396 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 364 7 1 3 5.1 O=C(O)COc1ccc(/C=C/C(=O)c2ccc(C3CCCCC3)cc2)cc1 nan
720233 49921 30 None 2 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 288 2 0 3 3.3 O=c1c(Cl)c(Cl)cnn1Cc1ccccc1Cl nan
CHEMBL1570760 49921 30 None 2 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 288 2 0 3 3.3 O=c1c(Cl)c(Cl)cnn1Cc1ccccc1Cl nan
9581015 59087 3 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709632 59087 3 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
154634314 186027 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 186027 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
3420390 178035 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 8 2 5 1.6 NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1 nan
CHEMBL467373 178035 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 8 2 5 1.6 NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1 nan
151577785 185971 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 185971 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
5513575 42482 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
CHEMBL1501743 42482 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
9581008 59234 3 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 59234 3 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
4623233 59732 7 None -12 3 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 320 2 0 4 4.4 Cc1nnc(-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12 nan
CHEMBL1736438 59732 7 None -12 3 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 320 2 0 4 4.4 Cc1nnc(-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12 nan
16193843 45819 5 None - 1 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 3 1 7 3.8 CC(C)CSC1=NSC2=NC(=O)/C(=C\c3coc4ccccc4c3=O)C(=N)N12 nan
CHEMBL1533415 45819 5 None - 1 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 3 1 7 3.8 CC(C)CSC1=NSC2=NC(=O)/C(=C\c3coc4ccccc4c3=O)C(=N)N12 nan
2286812 29253 28 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 nan
CHEMBL1384502 29253 28 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 nan
5768597 20571 6 None 3 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 320 3 1 5 3.1 N#C/C(=C/c1ccc(N2CCOCC2)o1)c1nc2ccccc2[nH]1 nan
CHEMBL1309475 20571 6 None 3 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 320 3 1 5 3.1 N#C/C(=C/c1ccc(N2CCOCC2)o1)c1nc2ccccc2[nH]1 nan
12005127 44553 3 None -3 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 333 6 0 4 4.6 COc1cc(/C=C(/C)[N+](=O)[O-])ccc1OCc1ccccc1Cl nan
CHEMBL1521989 44553 3 None -3 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 333 6 0 4 4.6 COc1cc(/C=C(/C)[N+](=O)[O-])ccc1OCc1ccccc1Cl nan
9581008 59234 3 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 59234 3 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
154634318 185417 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 185417 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
164627011 185824 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 185824 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
1346847 21001 8 None - 1 Human 6.6 pIC50 = 6.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
CHEMBL1312928 21001 8 None - 1 Human 6.6 pIC50 = 6.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
154634322 184798 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 184798 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
6109309 29767 3 None 3 3 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 355 5 1 4 4.0 CC(NC(=O)/C(C#N)=C/c1ccc(Cl)c([N+](=O)[O-])c1)c1ccccc1 nan
CHEMBL1388639 29767 3 None 3 3 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 355 5 1 4 4.0 CC(NC(=O)/C(C#N)=C/c1ccc(Cl)c([N+](=O)[O-])c1)c1ccccc1 nan
6622007 38806 6 None -9 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
CHEMBL1468612 38806 6 None -9 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
4798059 31709 9 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 296 4 1 3 4.3 COc1ccc2nc(C)cc(NCc3ccc(F)cc3)c2c1 nan
CHEMBL1407436 31709 9 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 296 4 1 3 4.3 COc1ccc2nc(C)cc(NCc3ccc(F)cc3)c2c1 nan
154634335 183901 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 183901 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
154634323 184021 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 184021 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145971442 162477 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 162477 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145953203 161988 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 161988 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
145955027 161990 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 161990 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
6226024 45413 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 442 7 3 6 3.7 O=C(CCCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
CHEMBL1529781 45413 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 442 7 3 6 3.7 O=C(CCCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
154634336 185486 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 185486 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634316 185760 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 185760 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
759209 35742 10 None -1 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 259 1 0 3 3.5 Cc1c(Cl)sn(-c2ccc(Cl)cc2)c1=O nan
CHEMBL1442788 35742 10 None -1 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 259 1 0 3 3.5 Cc1c(Cl)sn(-c2ccc(Cl)cc2)c1=O nan
648447 38564 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 3 1 7 2.1 COc1cccc(C2C3CN(C)CC=C3C(C#N)=C(N)C2(C#N)C#N)c1OC nan
CHEMBL1466582 38564 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 3 1 7 2.1 COc1cccc(C2C3CN(C)CC=C3C(C#N)=C(N)C2(C#N)C#N)c1OC nan
1527596 42842 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 7 2 7 4.9 CCOC(=O)c1c(-c2ccccc2)csc1NC(=O)/C(C#N)=C/c1ccc(O)c(OC)c1 nan
CHEMBL1504949 42842 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 7 2 7 4.9 CCOC(=O)c1c(-c2ccccc2)csc1NC(=O)/C(C#N)=C/c1ccc(O)c(OC)c1 nan
4406525 38198 6 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 294 1 0 4 2.6 CN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
CHEMBL1463795 38198 6 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 294 1 0 4 2.6 CN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
45489602 58963 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 58963 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
145971240 162537 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 162537 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
164610101 184292 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184292 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
1214651 59262 9 None -42 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 414 2 0 4 5.7 Cc1nnc(-c2cccc3ccccc23)c2cn(-c3cccc(Br)c3)nc12 nan
CHEMBL1718220 59262 9 None -42 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 414 2 0 4 5.7 Cc1nnc(-c2cccc3ccccc23)c2cn(-c3cccc(Br)c3)nc12 nan
154634327 184156 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184156 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
6619478 25732 3 None -9 2 Human 4.5 pIC50 = 4.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
CHEMBL1354041 25732 3 None -9 2 Human 4.5 pIC50 = 4.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
154634337 184751 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 184751 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
164627011 185824 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 185824 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
1024 16311 99 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 16311 99 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
154634320 186028 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 186028 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
154634331 183965 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 183965 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145952453 162238 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 162238 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
14286542 71876 4 None -4 4 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 401 2 3 4 2.9 CC1=CC2/C=C(\C)CCC(O)C(O)/C=C/C(=O)C23C(=O)NC(CC(C)C)C3C1C nan
CHEMBL1981103 71876 4 None -4 4 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 401 2 3 4 2.9 CC1=CC2/C=C(\C)CCC(O)C(O)/C=C/C(=O)C23C(=O)NC(CC(C)C)C3C1C nan
9581005 59319 2 None 21 2 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 359 4 2 6 2.3 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)NC(C)(C)C nan
CHEMBL1720530 59319 2 None 21 2 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 359 4 2 6 2.3 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)NC(C)(C)C nan
135650717 107726 5 None -2 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 4 3 6 4.3 Oc1ccc(/C=N/Nc2nc(-c3ccccc3F)nc3ccccc23)c(O)c1 nan
CHEMBL3196703 107726 5 None -2 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 4 3 6 4.3 Oc1ccc(/C=N/Nc2nc(-c3ccccc3F)nc3ccccc23)c(O)c1 nan
6226345 30929 8 None 4 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 5 3 4 2.9 CCCCN1C(=O)NC(=O)/C(=C(O)\C=C\c2c[nH]c3ccccc23)C1=O nan
CHEMBL1400236 30929 8 None 4 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 5 3 4 2.9 CCCCN1C(=O)NC(=O)/C(=C(O)\C=C\c2c[nH]c3ccccc23)C1=O nan
2868490 54032 10 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 3 0 3 5.6 COc1ccc(C=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)cc1OC nan
CHEMBL1608333 54032 10 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 3 0 3 5.6 COc1ccc(C=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)cc1OC nan
9581007 58958 2 None - 1 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1704074 58958 2 None - 1 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
16437205 31787 9 None -2 3 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 6 1 7 2.7 CCC1CCCCN1S(=O)(=O)c1ccc(NC(=O)c2nc(S(C)(=O)=O)ncc2Cl)cc1 nan
CHEMBL1407961 31787 9 None -2 3 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 6 1 7 2.7 CCC1CCCCN1S(=O)(=O)c1ccc(NC(=O)c2nc(S(C)(=O)=O)ncc2Cl)cc1 nan
1416931 23215 6 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1333032 23215 6 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
150149078 185762 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 185762 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
12533774 184936 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 184936 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634316 185760 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 185760 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
24792182 54799 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
CHEMBL1306983 54799 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
CHEMBL1616747 54799 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
57134579 162082 14 None - 1 Human 4.5 pIC50 = 4.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4169520 162082 14 None - 1 Human 4.5 pIC50 = 4.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145974046 162462 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 162462 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
13950957 156786 6 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 156786 6 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
9581012 59276 3 None - 1 Human 6.4 pIC50 = 6.4 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 415 5 2 6 3.3 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1718866 59276 3 None - 1 Human 6.4 pIC50 = 6.4 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 415 5 2 6 3.3 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccccc1 nan
6393553 46822 6 None 5 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 311 5 1 5 3.0 CC(NC(=O)/C(C#N)=C/c1ccc([N+](=O)[O-])o1)c1ccccc1 nan
CHEMBL1542492 46822 6 None 5 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 311 5 1 5 3.0 CC(NC(=O)/C(C#N)=C/c1ccc([N+](=O)[O-])o1)c1ccccc1 nan
145952039 162258 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 162258 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
2269231 45661 10 None 13 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1532025 45661 10 None 13 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
145959908 161513 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 161513 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
9581013 59398 3 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
CHEMBL1723578 59398 3 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
12533774 184936 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 184936 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
2841621 27492 6 None 2 3 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 4 0 4 3.8 CCOC(=O)C1=C(Cc2ccc(Cl)cc2)C(=O)c2ccccc2C1=O nan
CHEMBL1370183 27492 6 None 2 3 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 4 0 4 3.8 CCOC(=O)C1=C(Cc2ccc(Cl)cc2)C(=O)c2ccccc2C1=O nan
154634320 186028 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 186028 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
154634334 184843 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 184843 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145950576 162329 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
CHEMBL4173352 162329 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
56646802 67716 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
CHEMBL1914577 67716 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
5346366 41257 5 None 2 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1490915 41257 5 None 2 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
154634333 184632 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 184632 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
9581014 59681 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 337 4 2 6 1.5 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(N)=S nan
CHEMBL1734603 59681 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 337 4 2 6 1.5 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(N)=S nan
53258899 67725 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914586 67725 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
152243845 184316 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 184316 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
154634332 184544 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 184544 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634330 185370 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 185370 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
1214658 59161 9 None -4 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 392 4 0 5 5.5 COc1ccc(-n2cc3c(-c4ccc(-c5ccccc5)cc4)nnc(C)c3n2)cc1 nan
CHEMBL1713756 59161 9 None -4 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 392 4 0 5 5.5 COc1ccc(-n2cc3c(-c4ccc(-c5ccccc5)cc4)nnc(C)c3n2)cc1 nan
135399235 4071 55 None -26 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 4071 55 None -26 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 4071 55 None -26 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 4071 55 None -26 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
154634321 185415 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185415 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634336 185486 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 185486 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634314 186027 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 186027 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145955278 162009 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4168406 162009 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
21337671 67722 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
CHEMBL1914583 67722 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
68324914 185149 31 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 185149 31 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
7424594 52709 4 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 5 1 3 5.3 O=C(/C=C/c1ccco1)c1ccc(NC(=O)C23CC4CC(CC(C4)C2)C3)cc1 nan
CHEMBL1596753 52709 4 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 5 1 3 5.3 O=C(/C=C/c1ccco1)c1ccc(NC(=O)C23CC4CC(CC(C4)C2)C3)cc1 nan
145959592 161800 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4164993 161800 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
6202912 47945 8 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 502 9 3 8 3.7 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC nan
CHEMBL1552304 47945 8 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 502 9 3 8 3.7 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC nan
1477048 29521 17 None 23 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 5 0 5 4.3 CN(C)/C=C/C(=O)c1ccc(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)cc1 nan
CHEMBL1386711 29521 17 None 23 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 5 0 5 4.3 CN(C)/C=C/C(=O)c1ccc(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)cc1 nan
5936070 33831 9 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 427 4 1 4 6.4 CC(=O)Nc1sc(/C(C#N)=C/c2ccc(Cl)c(Cl)c2)nc1-c1ccc(C)cc1 nan
CHEMBL1424929 33831 9 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 427 4 1 4 6.4 CC(=O)Nc1sc(/C(C#N)=C/c2ccc(Cl)c(Cl)c2)nc1-c1ccc(C)cc1 nan
154634323 184021 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 184021 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
151271218 185573 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 185573 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
1609318 42386 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 297 12 2 4 3.4 C=CCCCCCCCCc1nc(SCC(=O)O)n[nH]1 nan
CHEMBL1500763 42386 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 297 12 2 4 3.4 C=CCCCCCCCCc1nc(SCC(=O)O)n[nH]1 nan
282594 45091 15 None -2 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 331 2 0 3 3.7 CC(=O)N(C1=C(Cl)C(=O)c2ccccc2C1=O)C1CCCCC1 nan
CHEMBL1526855 45091 15 None -2 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 331 2 0 3 3.7 CC(=O)N(C1=C(Cl)C(=O)c2ccccc2C1=O)C1CCCCC1 nan
5334290 25719 8 None 7 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 7 1 4 5.6 CCN(CC)c1ccc(/C=C(/C#N)c2nc3cc(C)ccc3[nH]2)c(OC(C)C)c1 nan
CHEMBL1353925 25719 8 None 7 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 7 1 4 5.6 CCN(CC)c1ccc(/C=C(/C#N)c2nc3cc(C)ccc3[nH]2)c(OC(C)C)c1 nan
4189659 27844 4 None 6 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1372770 27844 4 None 6 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
2269231 45661 10 None 13 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1532025 45661 10 None 13 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
5733585 40729 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
CHEMBL1487024 40729 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
4189659 27844 4 None 6 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1372770 27844 4 None 6 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
53258795 67729 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 67729 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
660319 10900 88 None - 1 Human 4.2 pIC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
CHEMBL1173787 10900 88 None - 1 Human 4.2 pIC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
5722655 19910 6 None 17 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 8 1 4 5.6 CCCOc1cc(N(CC)CC)ccc1/C=C(/C#N)c1nc2cc(C)ccc2[nH]1 nan
CHEMBL1304179 19910 6 None 17 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 8 1 4 5.6 CCCOc1cc(N(CC)CC)ccc1/C=C(/C#N)c1nc2cc(C)ccc2[nH]1 nan
1024 16311 99 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 16311 99 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
154634318 185417 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 185417 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
53258898 67731 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914592 67731 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
154634334 184843 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 184843 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634330 185370 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 185370 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164610101 184292 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184292 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
12138435 67715 25 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 67715 25 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
145951566 162215 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 162215 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
16103465 67726 2 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914587 67726 2 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
11957284 35707 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 3 2 8 5.0 Cc1nnc(NC(=O)c2sc3nc(-c4cccs4)cc(C(F)(F)F)c3c2N)s1 nan
CHEMBL1442537 35707 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 3 2 8 5.0 Cc1nnc(NC(=O)c2sc3nc(-c4cccs4)cc(C(F)(F)F)c3c2N)s1 nan
1542103 22284 24 None 2 3 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 418 4 0 6 4.2 Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1 nan
CHEMBL1325250 22284 24 None 2 3 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 418 4 0 6 4.2 Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1 nan
154634335 183901 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 183901 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
20992 195396 71 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 276 7 0 4 0.4 O=C1C=CC(=O)N1CCCCCCN1C(=O)C=CC1=O nan
CHEMBL567422 195396 71 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 276 7 0 4 0.4 O=C1C=CC(=O)N1CCCCCCN1C(=O)C=CC1=O nan
24789826 54780 0 None 56 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1307717 54780 0 None 56 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1616626 54780 0 None 56 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
1985027 32498 9 None 27 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 454 8 2 5 4.6 CCc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc1 nan
CHEMBL1413629 32498 9 None 27 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 454 8 2 5 4.6 CCc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc1 nan
12138434 67720 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
CHEMBL1914581 67720 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
164610101 184292 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184292 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
1803281 19865 8 None 15 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 337 4 1 3 3.0 CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1 nan
CHEMBL1303807 19865 8 None 15 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 337 4 1 3 3.0 CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1 nan
798024 35196 5 None - 1 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 245 3 1 4 1.7 N#C/C(=C\c1ccc(N2CCCCC2)o1)C(N)=O nan
CHEMBL1437947 35196 5 None - 1 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 245 3 1 4 1.7 N#C/C(=C\c1ccc(N2CCCCC2)o1)C(N)=O nan
6201879 27181 16 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 456 8 2 6 4.0 COc1cccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)c1 nan
CHEMBL1367928 27181 16 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 456 8 2 6 4.0 COc1cccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)c1 nan
154634332 184544 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 184544 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145954727 161871 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 161871 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
5767616 19399 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 370 5 1 5 4.3 CCOc1ccc(N(C)c2ccc(/C=C3/SC(=S)NC3=O)cc2)cc1 nan
CHEMBL1300169 19399 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 370 5 1 5 4.3 CCOc1ccc(N(C)c2ccc(/C=C3/SC(=S)NC3=O)cc2)cc1 nan
152550147 184746 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 184746 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634322 184798 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 184798 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
1346847 21001 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
CHEMBL1312928 21001 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
10868388 161584 43 None - 1 Human 4.1 pIC50 = 4.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161599 161584 43 None - 1 Human 4.1 pIC50 = 4.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
1502520 34278 21 None -9 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
CHEMBL1428840 34278 21 None -9 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
3860640 149299 42 None -13 3 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 331 2 3 3 3.7 Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL394883 149299 42 None -13 3 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 331 2 3 3 3.7 Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1 nan
1231538 27311 23 None -1 3 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1368962 27311 23 None -1 3 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
4559736 34450 3 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 254 2 2 4 2.7 Nc1[nH]c2cc([N+](=O)[O-])ccc2c1-c1ccccn1 nan
CHEMBL1430125 34450 3 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 254 2 2 4 2.7 Nc1[nH]c2cc([N+](=O)[O-])ccc2c1-c1ccccn1 nan
326869 112313 3 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112313 3 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634331 183965 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 183965 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
149708825 185809 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 185809 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
2277094 48751 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1560901 48751 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
1205881 35936 5 None 23 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1444708 35936 5 None 23 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
145958445 161582 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161574 161582 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145959306 161765 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4164556 161765 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
145949189 162187 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 162187 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
154634326 184509 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 184509 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
2732121 38292 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 306 3 0 4 3.6 CC(C)c1ccc(N2C(=O)/C(=C/N(C)C)SC2=S)cc1 nan
CHEMBL1464544 38292 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 306 3 0 4 3.6 CC(C)c1ccc(N2C(=O)/C(=C/N(C)C)SC2=S)cc1 nan
110720191 161907 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4166802 161907 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
3276705 46131 9 None - 1 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 521 8 2 6 4.3 CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cccnc2Cl)c(NC(=O)c2cccnc2Cl)c1 nan
CHEMBL1536628 46131 9 None - 1 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 521 8 2 6 4.3 CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cccnc2Cl)c(NC(=O)c2cccnc2Cl)c1 nan
6974996 71675 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 389 6 0 6 3.6 CC/N=C1\S/C(=C\c2cc(OC)c(N3CCCC3)cc2OC)C(=O)N1CC nan
CHEMBL1975147 71675 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 389 6 0 6 3.6 CC/N=C1\S/C(=C\c2cc(OC)c(N3CCCC3)cc2OC)C(=O)N1CC nan
154634327 184156 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184156 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
18158890 23315 4 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL1333832 23315 4 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
1348329 26043 12 None 3 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1357976 26043 12 None 3 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
3804843 42001 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 321 1 1 6 2.1 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3ccsc3)C2C1 nan
CHEMBL1497386 42001 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 321 1 1 6 2.1 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3ccsc3)C2C1 nan
18158890 23315 4 None - 1 Human 5.0 pIC50 = 5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL1333832 23315 4 None - 1 Human 5.0 pIC50 = 5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
4659569 22131 95 None - 1 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 None
CHEMBL1324 22131 95 None - 1 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 None
5281081 205922 81 None - 1 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 None
CHEMBL953 205922 81 None - 1 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 None
2882 1183 58 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 1183 58 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 1183 58 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 1183 58 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 1183 58 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
2161 8645 109 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
Drug Central 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 None
CHEMBL1096 8645 109 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
Drug Central 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 None
2471 729 104 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
427 729 104 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
4837 729 104 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
CHEMBL1072 729 104 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
DB00887 729 104 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
2882 1183 58 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 1183 58 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 1183 58 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 1183 58 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 1183 58 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
50294 215990 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 371 5 2 6 2.5 CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O None
3325 2307 48 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
44564 2307 48 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
9743 2307 48 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
CHEMBL1201266 2307 48 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
DB06794 2307 48 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
3325 2307 48 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
44564 2307 48 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
9743 2307 48 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
CHEMBL1201266 2307 48 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
DB06794 2307 48 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
2918 2174 117 None -4570 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
2918 2174 117 None -4570 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
3845 2174 117 None -4570 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 2174 117 None -4570 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
CHEMBL299155 2174 117 None -4570 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 2174 117 None -4570 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
DB11937 2174 117 None -4570 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 2174 117 None -4570 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
2471 729 104 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
427 729 104 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
4837 729 104 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
CHEMBL1072 729 104 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
DB00887 729 104 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
118985385 1671 105 None - 1 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
1258 1671 105 None - 1 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
3440 1671 105 None - 1 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
4839 1671 105 None - 1 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
CHEMBL35 1671 105 None - 1 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
DB00695 1671 105 None - 1 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
2936 85 0 None -3 4 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 436 20 3 5 5.0 CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO 20361937
56947016 85 0 None -3 4 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 436 20 3 5 5.0 CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO 20361937
2920 2948 98 None -2344 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
54742459 2948 98 None -2344 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
8546 2948 98 None -2344 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
CHEMBL177880 2948 98 None -2344 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
2918 2174 117 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 2174 117 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 2174 117 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 2174 117 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
2918 2174 117 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 2174 117 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 2174 117 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 2174 117 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
135399235 4071 55 None -26 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2919 4071 55 None -26 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5722 4071 55 None -26 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
CHEMBL28079 4071 55 None -26 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2920 2948 98 None 2344 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
54742459 2948 98 None 2344 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
8546 2948 98 None 2344 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
CHEMBL177880 2948 98 None 2344 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
135399235 4071 55 None 26 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2919 4071 55 None 26 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5722 4071 55 None 26 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
CHEMBL28079 4071 55 None 26 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5280343 187691 119 None -8 7 Human 8.3 pIC50 = 8.3 Functional
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL1520590 187691 119 None -8 7 Human 8.3 pIC50 = 8.3 Functional
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL50 187691 119 None -8 7 Human 8.3 pIC50 = 8.3 Functional
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
2745687 920 28 None 10 3 Human 6.7 pIC50 = 6.7 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 920 28 None 10 3 Human 6.7 pIC50 = 6.7 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 920 28 None 10 3 Human 6.7 pIC50 = 6.7 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
2745687 920 28 None 10 3 Human 5.0 pIC50 = 5.0 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 920 28 None 10 3 Human 5.0 pIC50 = 5.0 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 920 28 None 10 3 Human 5.0 pIC50 = 5.0 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
12138435 67715 25 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
CHEMBL1914576 67715 25 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
71733650 90412 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 90412 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
694463 87052 82 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL2333943 87052 82 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71733848 90430 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
CHEMBL2392179 90430 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
71733848 90430 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90430 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
71733848 90430 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90430 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
135399235 4071 55 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
2919 4071 55 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
5722 4071 55 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
CHEMBL28079 4071 55 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
71733845 90427 0 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90427 0 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
4488 201332 105 None - 1 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 201332 105 None - 1 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
71733651 90413 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392162 90413 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733651 90413 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 90413 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71734940 90414 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm400587g
CHEMBL2392163 90414 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm400587g
118985385 1671 105 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 1671 105 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 1671 105 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 1671 105 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 1671 105 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 1671 105 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71733650 90412 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 90412 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71733843 90425 3 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90425 3 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90425 3 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 90425 3 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90425 3 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90425 3 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 90425 3 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
CHEMBL2392174 90425 3 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
CHEMBL2425818 90425 3 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
2920 2948 98 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 2948 98 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 2948 98 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 2948 98 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
71734944 90399 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
CHEMBL2392148 90399 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
71733653 90416 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392165 90416 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
2882 1183 58 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 1183 58 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 1183 58 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 1183 58 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 1183 58 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
71734939 90395 1 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392144 90395 1 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733847 90429 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 90429 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
92934 169090 89 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in human HT29 cells by DMR assayAgonist activity at human GPR35 expressed in human HT29 cells by DMR assay
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
CHEMBL443738 169090 89 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in human HT29 cells by DMR assayAgonist activity at human GPR35 expressed in human HT29 cells by DMR assay
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
12403015 111008 1 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 300 2 4 4 0.8 O=C(O)c1cc(=O)c2c(ccc3c(=O)cc(C(=O)O)[nH]c32)[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL3277775 111008 1 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 300 2 4 4 0.8 O=C(O)c1cc(=O)c2c(ccc3c(=O)cc(C(=O)O)[nH]c32)[nH]1 10.1021/acs.jmedchem.6b01431
135399235 4071 55 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2919 4071 55 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
5722 4071 55 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
CHEMBL28079 4071 55 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
54676038 38487 73 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1466 38487 73 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
54676038 38487 73 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 38487 73 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
71733846 90428 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90428 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71735030 90403 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
CHEMBL2392152 90403 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
71735030 90403 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
CHEMBL2392152 90403 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
71734942 90397 0 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392146 90397 0 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
271643 32561 61 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1414071 32561 61 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71733844 90426 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392175 90426 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71735034 90406 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392155 90406 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
10857978 114746 4 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
CHEMBL3347429 114746 4 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
137652009 156972 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 156972 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137652009 156972 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 156972 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733848 90430 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90430 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
2295463 91789 27 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 91789 27 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
71733843 90425 3 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90425 3 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90425 3 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137657450 159048 3 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159048 3 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137657450 159048 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159048 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137657450 159048 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159048 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71733651 90413 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 90413 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733939 90433 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
CHEMBL2392182 90433 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
137636652 155508 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4062531 155508 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
13950958 157086 4 None - 0 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157086 4 None - 0 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
71733749 90423 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90423 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71733749 90423 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90423 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
13950958 157086 4 None - 0 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157086 4 None - 0 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
4488 201332 105 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 201332 105 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
2918 2174 117 None - 0 Human 3.8 pEC50 = 3.8 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
3845 2174 117 None - 0 Human 3.8 pEC50 = 3.8 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
CHEMBL299155 2174 117 None - 0 Human 3.8 pEC50 = 3.8 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
DB11937 2174 117 None - 0 Human 3.8 pEC50 = 3.8 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
137653726 158130 3 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158130 3 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733939 90433 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
CHEMBL2392182 90433 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
71735035 90407 0 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm400587g
CHEMBL2392156 90407 0 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm400587g
71733748 90422 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 90422 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733748 90422 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392171 90422 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733748 90422 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 90422 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733744 90418 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392167 90418 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733744 90418 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90418 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733649 90411 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 90411 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733744 90418 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90418 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
135399235 4071 55 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4071 55 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4071 55 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4071 55 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71733845 90427 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90427 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733845 90427 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90427 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733649 90411 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 90411 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
135468531 90393 23 None - 0 Mouse 4.8 pEC50 = 4.8 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90393 23 None - 0 Mouse 4.8 pEC50 = 4.8 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733743 90417 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
CHEMBL2392166 90417 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
5464105 57527 60 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
CHEMBL167055 57527 60 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
725495 65205 58 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 65205 58 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
725495 65205 58 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 65205 58 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
71733651 90413 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 90413 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137655259 158422 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096105 158422 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
11312 111030 61 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3278560 111030 61 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71733744 90418 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90418 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
4921319 106975 51 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3183248 106975 51 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
135399235 4071 55 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4071 55 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4071 55 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4071 55 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
137662152 158844 4 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 158844 4 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2920 2948 98 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
54742459 2948 98 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
8546 2948 98 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL177880 2948 98 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
2920 2948 98 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 2948 98 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 2948 98 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 2948 98 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
71733649 90411 0 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 90411 0 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
657910 53171 47 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1600989 53171 47 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
71734943 90398 0 None - 1 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392147 90398 0 None - 1 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733847 90429 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 90429 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
71733746 90420 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 90420 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
2882 1183 58 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 1183 58 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 1183 58 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 1183 58 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 1183 58 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
71733653 90416 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392165 90416 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
3254949 114747 7 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3347474 114747 7 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
782693 157696 31 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4088382 157696 31 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71735036 90408 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90408 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
2918 2174 117 None - 0 Human 3.7 pEC50 = 3.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
3845 2174 117 None - 0 Human 3.7 pEC50 = 3.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
CHEMBL299155 2174 117 None - 0 Human 3.7 pEC50 = 3.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
DB11937 2174 117 None - 0 Human 3.7 pEC50 = 3.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
71733843 90425 3 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90425 3 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90425 3 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
3870203 58022 52 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 200 2 2 6 0.9 O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL168276 58022 52 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 200 2 2 6 0.9 O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
135399235 4071 55 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4071 55 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4071 55 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4071 55 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
71733842 90424 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392173 90424 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137658268 159115 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 159115 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
137658268 159115 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 159115 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
633803 114748 11 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347475 114748 11 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71734941 90396 2 None - 1 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392145 90396 2 None - 1 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
10857978 114746 4 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
CHEMBL3347429 114746 4 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
71733747 90421 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
CHEMBL2392170 90421 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
71733749 90423 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392172 90423 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71733747 90421 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
CHEMBL2392170 90421 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
73294510 91787 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425823 91787 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
135468531 90393 23 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90393 23 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
135468531 90393 23 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90393 23 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733650 90412 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 90412 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
137646097 157358 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4084237 157358 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
71733749 90423 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90423 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71735032 90404 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392153 90404 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
71733745 90419 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392168 90419 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
71733744 90418 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90418 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733652 90415 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392164 90415 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
137652009 156972 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 156972 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137647862 157111 3 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4081445 157111 3 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
633803 114748 11 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347475 114748 11 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71734946 90402 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
CHEMBL2392151 90402 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
135468531 90393 23 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm4009373
CHEMBL2392141 90393 23 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm4009373
71733940 90434 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90434 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
71733940 90434 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90434 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
71733745 90419 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392168 90419 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733745 90419 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392168 90419 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
4488 201332 105 None - 1 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 201332 105 None - 1 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
1493 97639 74 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL273386 97639 74 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71733648 90410 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 90410 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
71733743 90417 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
CHEMBL2392166 90417 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
12138435 67715 25 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
CHEMBL1914576 67715 25 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
135399235 4071 55 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
2919 4071 55 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
5722 4071 55 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
CHEMBL28079 4071 55 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
71733749 90423 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90423 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
137648473 157448 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 157448 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137648473 157448 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 157448 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733748 90422 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 90422 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
135399235 4071 55 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4071 55 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4071 55 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4071 55 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
40119 84381 24 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assayAgonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assay
ChEMBL 312 1 1 6 1.2 O=C1c2ccccc2S(=O)(=O)c2cc(-c3nn[nH]n3)ccc21 10.1021/acsmedchemlett.7b00510
CHEMBL22336 84381 24 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assayAgonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assay
ChEMBL 312 1 1 6 1.2 O=C1c2ccccc2S(=O)(=O)c2cc(-c3nn[nH]n3)ccc21 10.1021/acsmedchemlett.7b00510
71735036 90408 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392157 90408 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735036 90408 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90408 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71735036 90408 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90408 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
2295463 91789 27 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 91789 27 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
135399235 4071 55 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4071 55 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4071 55 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4071 55 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71735030 90403 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
CHEMBL2392152 90403 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
71733938 90432 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392181 90432 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
13950958 157086 4 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157086 4 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
11872 106977 61 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3183545 106977 61 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
73294509 91786 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425822 91786 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733648 90410 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 90410 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
71733842 90424 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392173 90424 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
73294321 91785 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
CHEMBL2425820 91785 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
73294320 91784 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425819 91784 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
71733747 90421 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
CHEMBL2392170 90421 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
3325 2307 48 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
44564 2307 48 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
9743 2307 48 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
CHEMBL1201266 2307 48 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
DB06794 2307 48 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
2161 8645 109 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1021/acs.jmedchem.6b01431
CHEMBL1096 8645 109 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1021/acs.jmedchem.6b01431
71733848 90430 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90430 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
13681 114745 63 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347428 114745 63 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71734944 90399 0 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
CHEMBL2392148 90399 0 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
135399235 4071 55 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4071 55 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4071 55 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4071 55 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71733846 90428 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90428 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71733846 90428 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90428 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
21236027 158441 4 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096323 158441 4 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
71733652 90415 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392164 90415 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
13950957 156786 6 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4077503 156786 6 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
21982642 90394 2 None - 1 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm400587g
CHEMBL2392142 90394 2 None - 1 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm400587g
71734946 90402 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
CHEMBL2392151 90402 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
71734946 90402 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
CHEMBL2392151 90402 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
71735036 90408 0 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90408 0 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137646246 157193 3 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157193 3 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 1183 58 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 1183 58 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 1183 58 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 1183 58 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 1183 58 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
71735031 90400 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392149 90400 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71735031 90400 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392149 90400 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
4659569 22131 95 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
CHEMBL1324 22131 95 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
71733845 90427 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90427 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733940 90434 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90434 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
73294508 1118 0 None - 1 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
9742 1118 0 None - 1 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
CHEMBL2425821 1118 0 None - 1 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
137662152 158844 4 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 158844 4 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137662152 158844 4 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 158844 4 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2920 2948 98 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
54742459 2948 98 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
8546 2948 98 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
CHEMBL177880 2948 98 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
2920 2948 98 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
54742459 2948 98 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
8546 2948 98 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL177880 2948 98 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
71735036 90408 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90408 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137646246 157193 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157193 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
137646246 157193 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157193 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 1183 58 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
741 1183 58 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
7608 1183 58 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL428880 1183 58 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
DB01003 1183 58 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
2882 1183 58 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 1183 58 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 1183 58 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 1183 58 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 1183 58 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
9492 5395 39 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc([N+](=O)[O-])c(O)c1 10.1039/C2MD20210G
CHEMBL107513 5395 39 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc([N+](=O)[O-])c(O)c1 10.1039/C2MD20210G
11872 106977 61 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3183545 106977 61 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
4921319 106975 51 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3183248 106975 51 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71735032 90404 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392153 90404 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
3495594 17007 26 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
CHEMBL1256291 17007 26 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
13681 114745 63 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347428 114745 63 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
1231538 27311 23 None - 0 Human 6.3 pEC50 = 6.3 Binding
Antagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assayAntagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assay
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1368962 27311 23 None - 0 Human 6.3 pEC50 = 6.3 Binding
Antagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assayAntagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assay
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
5281081 205922 81 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL953 205922 81 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
137632988 155827 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 155827 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
6191 114743 47 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc(O)c1[N+](=O)[O-] 10.1039/C2MD20210G
CHEMBL3347393 114743 47 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc(O)c1[N+](=O)[O-] 10.1039/C2MD20210G
71733847 90429 0 None - 1 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 90429 0 None - 1 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
3254949 114747 7 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3347474 114747 7 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
73294319 91788 0 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425824 91788 0 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
135399235 4071 55 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4071 55 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4071 55 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4071 55 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
118985385 1671 105 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 1671 105 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 1671 105 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 1671 105 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 1671 105 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 1671 105 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71733846 90428 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90428 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71733844 90426 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392175 90426 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733846 90428 0 None - 1 Mouse 5.2 pEC50 = 5.2 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90428 0 None - 1 Mouse 5.2 pEC50 = 5.2 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
5281081 205922 81 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL953 205922 81 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
137653726 158130 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158130 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2918 2174 117 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
3845 2174 117 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
CHEMBL299155 2174 117 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
DB11937 2174 117 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
71734943 90398 0 None - 1 Rat 5.2 pEC50 = 5.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392147 90398 0 None - 1 Rat 5.2 pEC50 = 5.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
20486870 60771 5 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
CHEMBL1765162 60771 5 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
71733647 90409 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
CHEMBL2392158 90409 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
137653726 158130 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158130 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
10800 162857 55 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL419564 162857 55 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71735033 90405 0 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm400587g
CHEMBL2392154 90405 0 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm400587g
71733746 90420 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 90420 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
137632988 155827 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 155827 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 1183 58 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
741 1183 58 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
7608 1183 58 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL428880 1183 58 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
DB01003 1183 58 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
137632781 155746 3 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 155746 3 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137641148 156505 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4073902 156505 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
4659569 22131 95 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
CHEMBL1324 22131 95 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
11312 111030 61 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3278560 111030 61 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
135468531 90393 23 None - 0 Rat 5.1 pEC50 = 5.1 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90393 23 None - 0 Rat 5.1 pEC50 = 5.1 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733647 90409 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
CHEMBL2392158 90409 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
10800 162857 55 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL419564 162857 55 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
5464105 57527 60 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
CHEMBL167055 57527 60 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
137654727 158199 3 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4093683 158199 3 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71733746 90420 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 90420 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
5066064 156830 6 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4078055 156830 6 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
3495594 17007 26 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
CHEMBL1256291 17007 26 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
71733648 90410 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 90410 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
137658472 159253 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 159253 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137658472 159253 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 159253 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71734945 90401 0 None - 1 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392150 90401 0 None - 1 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
10752 204103 91 None - 0 Human 4.0 pEC50 = 4.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL83294 204103 91 None - 0 Human 4.0 pEC50 = 4.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
137643561 157508 3 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4085935 157508 3 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
137632781 155746 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 155746 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137632781 155746 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 155746 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
54676038 38487 73 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 38487 73 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
135399235 4071 55 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4071 55 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4071 55 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4071 55 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2882 1183 58 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 1183 58 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 1183 58 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 1183 58 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 1183 58 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
71733940 90434 0 None - 1 Rat 6.0 pEC50 = 6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90434 0 None - 1 Rat 6.0 pEC50 = 6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
5281855 201155 101 None - 0 Human 7.0 pIC50 = 7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 201155 101 None - 0 Human 7.0 pIC50 = 7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
10752 204103 91 None - 0 Human 4.0 pIC50 = 4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL83294 204103 91 None - 0 Human 4.0 pIC50 = 4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
2745687 920 28 None - 1 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 920 28 None - 1 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 920 28 None - 1 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
725495 65205 58 None - 0 Human 6.0 pIC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 65205 58 None - 0 Human 6.0 pIC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
16103462 67727 16 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 67727 16 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
153273978 194252 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 194252 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 194252 1 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
694463 87052 82 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL2333943 87052 82 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
135399235 4071 55 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 4071 55 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 4071 55 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 4071 55 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
4488 201332 105 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 201332 105 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
137652009 156972 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 156972 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137635873 155331 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 539 6 1 6 5.0 O=C(Nc1ccc2nc([S+]([O-])Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL4060393 155331 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 539 6 1 6 5.0 O=C(Nc1ccc2nc([S+]([O-])Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
271643 32561 61 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1414071 32561 61 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
137636652 155508 3 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4062531 155508 3 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
137655259 158422 3 None - 0 Human 4.8 pIC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096105 158422 3 None - 0 Human 4.8 pIC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
5280343 187691 119 None - 32 Human 4.8 pIC50 = 4.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 187691 119 None - 32 Human 4.8 pIC50 = 4.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 187691 119 None - 32 Human 4.8 pIC50 = 4.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
411 2555 86 None - 3 Human 5.8 pIC50 = 5.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 2555 86 None - 3 Human 5.8 pIC50 = 5.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 2555 86 None - 3 Human 5.8 pIC50 = 5.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
137647862 157111 3 None - 0 Human 5.8 pIC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4081445 157111 3 None - 0 Human 5.8 pIC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
137647638 157096 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 537 6 1 6 6.5 CC(Sc1nc2ccc(NC(=O)c3ccccc3C(=O)N3CCOCC3)cc2s1)c1ccc(Cl)cc1 10.1016/j.bmcl.2016.12.012
CHEMBL4081331 157096 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 537 6 1 6 6.5 CC(Sc1nc2ccc(NC(=O)c3ccccc3C(=O)N3CCOCC3)cc2s1)c1ccc(Cl)cc1 10.1016/j.bmcl.2016.12.012
5215 2354 128 None - 1 Human 4.7 pIC50 = 4.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 2354 128 None - 1 Human 4.7 pIC50 = 4.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 2354 128 None - 1 Human 4.7 pIC50 = 4.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
2745687 920 28 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 920 28 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 920 28 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
5281672 56260 116 None - 0 Human 5.7 pIC50 = 5.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 56260 116 None - 0 Human 5.7 pIC50 = 5.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
782693 157696 31 None - 0 Human 4.7 pIC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4088382 157696 31 None - 0 Human 4.7 pIC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
137653726 158130 3 None - 0 Human 7.6 pIC50 = 7.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158130 3 None - 0 Human 7.6 pIC50 = 7.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
657910 53171 47 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1600989 53171 47 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
2286812 29253 28 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 29253 28 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
137646097 157358 3 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4084237 157358 3 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
5281605 204018 108 None - 0 Human 4.6 pIC50 = 4.6 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 204018 108 None - 0 Human 4.6 pIC50 = 4.6 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
137658268 159115 3 None - 0 Human 5.5 pIC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 159115 3 None - 0 Human 5.5 pIC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
135403802 26326 52 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 26326 52 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
5328791 203276 60 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 203276 60 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
137646246 157193 3 None - 0 Human 7.5 pIC50 = 7.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157193 3 None - 0 Human 7.5 pIC50 = 7.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
137648473 157448 3 None - 0 Human 6.5 pIC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 157448 3 None - 0 Human 6.5 pIC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
21236027 158441 4 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096323 158441 4 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
13950957 156786 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4077503 156786 6 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
137632781 155746 3 None - 0 Human 6.4 pIC50 = 6.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 155746 3 None - 0 Human 6.4 pIC50 = 6.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
5491415 74942 15 None - 0 Human 6.4 pIC50 = 6.4 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 74942 15 None - 0 Human 6.4 pIC50 = 6.4 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
2918 2174 117 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
3845 2174 117 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
CHEMBL299155 2174 117 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
DB11937 2174 117 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
73157 193689 26 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 193689 26 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
1231538 27311 23 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1368962 27311 23 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
137657450 159048 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159048 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
3884 44247 72 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 44247 72 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
137641148 156505 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4073902 156505 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
20486870 60771 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
CHEMBL1765162 60771 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
2286812 29253 28 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 29253 28 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
137646699 157195 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 555 6 1 7 4.6 O=C(Nc1ccc2nc(S(=O)(=O)Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL4082295 157195 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 555 6 1 7 4.6 O=C(Nc1ccc2nc(S(=O)(=O)Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
13950958 157086 4 None - 0 Human 7.3 pIC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157086 4 None - 0 Human 7.3 pIC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
2745687 920 28 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 920 28 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 920 28 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
137654727 158199 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4093683 158199 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137632988 155827 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 155827 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
5346366 41257 5 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1490915 41257 5 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
137658472 159253 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 159253 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137662152 158844 4 None - 0 Human 8.1 pIC50 = 8.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 158844 4 None - 0 Human 8.1 pIC50 = 8.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
5066064 156830 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4078055 156830 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
137643561 157508 3 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4085935 157508 3 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
71733843 90425 3 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90425 3 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90425 3 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733843 90425 3 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90425 3 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90425 3 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733843 90425 3 None - 1 Human 8.3 pKd = 8.3 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90425 3 None - 1 Human 8.3 pKd = 8.3 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90425 3 None - 1 Human 8.3 pKd = 8.3 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733843 90425 3 None - 1 Human 8.2 pKd = 8.2 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90425 3 None - 1 Human 8.2 pKd = 8.2 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90425 3 None - 1 Human 8.2 pKd = 8.2 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
73294508 1118 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
9742 1118 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
CHEMBL2425821 1118 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
71733748 90422 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392171 90422 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733848 90430 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
CHEMBL2392179 90430 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
73294320 91784 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425819 91784 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
73294321 91785 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
CHEMBL2425820 91785 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
73294319 91788 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425824 91788 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
71735035 90407 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm4009373
CHEMBL2392156 90407 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm4009373
2920 2948 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 2948 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 2948 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 2948 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
71733650 90412 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392161 90412 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71733648 90410 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm4009373
CHEMBL2392159 90410 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm4009373
71733746 90420 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392169 90420 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
21982642 90394 2 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm4009373
CHEMBL2392142 90394 2 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm4009373
71733652 90415 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392164 90415 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733842 90424 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392173 90424 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733847 90429 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm4009373
CHEMBL2392178 90429 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm4009373
71733743 90417 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm4009373
CHEMBL2392166 90417 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm4009373
71734941 90396 2 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392145 90396 2 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734943 90398 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392147 90398 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734940 90414 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm4009373
CHEMBL2392163 90414 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm4009373
71733749 90423 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392172 90423 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
73294510 91787 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425823 91787 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735036 90408 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392157 90408 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733846 90428 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm4009373
CHEMBL2392177 90428 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm4009373
71733647 90409 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm4009373
CHEMBL2392158 90409 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm4009373
2882 1183 58 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 1183 58 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 1183 58 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 1183 58 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 1183 58 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
71733651 90413 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392162 90413 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733940 90434 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm4009373
CHEMBL2392183 90434 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm4009373
71733653 90416 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392165 90416 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
71734945 90401 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392150 90401 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734939 90395 1 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392144 90395 1 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
118985385 1671 105 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 1671 105 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 1671 105 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 1671 105 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 1671 105 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 1671 105 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71735031 90400 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392149 90400 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733845 90427 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392176 90427 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734944 90399 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm4009373
CHEMBL2392148 90399 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm4009373
4488 201332 105 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 201332 105 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
71733937 90431 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 379 6 2 5 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(OCC2CC2)cc1 10.1021/jm4009373
CHEMBL2392180 90431 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 379 6 2 5 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(OCC2CC2)cc1 10.1021/jm4009373
54676038 38487 73 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 38487 73 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
71733649 90411 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392160 90411 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733747 90421 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
CHEMBL2392170 90421 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
135399235 4071 55 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2919 4071 55 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
5722 4071 55 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
CHEMBL28079 4071 55 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2745687 920 28 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 920 28 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 920 28 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
73294509 91786 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425822 91786 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735033 90405 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm4009373
CHEMBL2392154 90405 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm4009373
71735032 90404 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392153 90404 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
71733843 90425 3 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90425 3 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90425 3 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733744 90418 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392167 90418 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
2295463 91789 27 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 91789 27 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
71733939 90433 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm4009373
CHEMBL2392182 90433 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm4009373
12138435 67715 25 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL1914576 67715 25 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71734942 90397 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392146 90397 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71735030 90403 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
CHEMBL2392152 90403 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
71735034 90406 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392155 90406 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71734946 90402 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
CHEMBL2392151 90402 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
2286812 29253 28 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 29253 28 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
71733938 90432 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392181 90432 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733745 90419 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392168 90419 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733844 90426 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392175 90426 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
92934 169090 89 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
CHEMBL443738 169090 89 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
4488 201332 105 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 None
CHEMBL63323 201332 105 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 None
118985385 1671 105 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
1258 1671 105 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
3440 1671 105 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
4839 1671 105 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
CHEMBL35 1671 105 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
DB00695 1671 105 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
2882 1183 58 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 1183 58 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 1183 58 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 1183 58 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 1183 58 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
54676038 38487 73 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O None
CHEMBL1466 38487 73 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O None
2745687 920 28 None - 1 Human 7.9 pKi = 7.9 Binding
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
9741 920 28 None - 1 Human 7.9 pKi = 7.9 Binding
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
CHEMBL1708510 920 28 None - 1 Human 7.9 pKi = 7.9 Binding
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
2745687 920 28 None - 1 Human 7.4 pKi = 7.4 Binding
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 920 28 None - 1 Human 7.4 pKi = 7.4 Binding
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 920 28 None - 1 Human 7.4 pKi = 7.4 Binding
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
73294508 1118 0 None - 1 Human 9.2 pKi = 9.2 Binding
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932
9742 1118 0 None - 1 Human 9.2 pKi = 9.2 Binding
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932
CHEMBL2425821 1118 0 None - 1 Human 9.2 pKi = 9.2 Binding
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932